drugset / Trial / NCT02619747

Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients

NCT02619747 ↗

Phase 3 Terminated 16 enrolled Reckitt Benckiser Healthcare (UK) Limited
RandomizedCrossoverOpen-labelOther

Summary

Multi-centre, randomised, open-label, placebo-controlled, two-period crossover study of 4 hour pH monitoring following a refluxogenic meal and drink.

Timeline

Start
2014-04
Primary completion
2017-03-31
Completion
2017-03-31

Outcome

Outcome not reported

Stopped (Enrollment): “Problems with recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Compound Sodium Alginate Oral Suspension sachet Unknown 20 ml Oral